newsfilter
← Latest News
GlobeNewswire·

Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026

DURHAM, N.C., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs